ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

September 9, 2005

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996